Pancreatic Cancer

Pancreatic cancer is among the most lethal cancers, characterized by rapid progression and resistance to therapy. ALDH1A3 contributes to the survival and adaptability of pancreatic cancer cells, providing an opportunity for targeted therapies to disrupt these pathways and enhance treatment outcomes.